Results 271 to 280 of about 2,969,292 (313)
Some of the next articles are maybe not open access.
Annals of Nuclear Medicine, 1998
Therapeutic nuclear medicine is rapidly developing as an additional treatment modality in oncology. Its unique characteristics are the systemic, yet selective delivery of radiation doses in target tissues, its non-invasiveness, the relative lack of immediate and late side effects, and the advantage that uptake and retention in the tumor can be pre ...
openaire +2 more sources
Therapeutic nuclear medicine is rapidly developing as an additional treatment modality in oncology. Its unique characteristics are the systemic, yet selective delivery of radiation doses in target tissues, its non-invasiveness, the relative lack of immediate and late side effects, and the advantage that uptake and retention in the tumor can be pre ...
openaire +2 more sources
Nature Reviews Drug Discovery, 2010
Oncology has become one of the major focus areas for pharmaceutical and biotechnology companies. In 2009, ~16,000 of the ~40,000 Phase I, II and III trials listed on ClinicalTrials.gov were related to cancer (~40%). This large interest stems from the existence of high unmet need for improved treatments of multiple types of cancer and the substantial ...
openaire +2 more sources
Oncology has become one of the major focus areas for pharmaceutical and biotechnology companies. In 2009, ~16,000 of the ~40,000 Phase I, II and III trials listed on ClinicalTrials.gov were related to cancer (~40%). This large interest stems from the existence of high unmet need for improved treatments of multiple types of cancer and the substantial ...
openaire +2 more sources
2023
Abstract Heart failure can be caused by a range of cardiotoxic cancer therapies. The most common are anthracycline chemotherapy and human epidermal growth factor receptor 2 (HER2)-targeted therapies. However, with the development of targeted molecular cancer therapies, the number of cancer treatments causing heart failure are increasing ...
Dimitrios Farmakis +3 more
openaire +1 more source
Abstract Heart failure can be caused by a range of cardiotoxic cancer therapies. The most common are anthracycline chemotherapy and human epidermal growth factor receptor 2 (HER2)-targeted therapies. However, with the development of targeted molecular cancer therapies, the number of cancer treatments causing heart failure are increasing ...
Dimitrios Farmakis +3 more
openaire +1 more source
Nature, 2004
Disruption of the normal regulation of cell-cycle progression and division lies at the heart of the events leading to cancer. Complex networks of regulatory factors, the tumour microenvironment and stress signals, such as those resulting from damaged DNA, dictate whether cancer cells proliferate or die.
openaire +2 more sources
Disruption of the normal regulation of cell-cycle progression and division lies at the heart of the events leading to cancer. Complex networks of regulatory factors, the tumour microenvironment and stress signals, such as those resulting from damaged DNA, dictate whether cancer cells proliferate or die.
openaire +2 more sources
Journal of Pharmaceutical Negative Results, 2023
Cancer is a threat to humanity in this era. The new cases are sharply increasing. The cancer death also a major problem of the recent time. In this review the various treatment options available are described. The cancer types also explained. The WHO data of various new cases of cancer are depicted in the form of graph.
openaire +1 more source
Cancer is a threat to humanity in this era. The new cases are sharply increasing. The cancer death also a major problem of the recent time. In this review the various treatment options available are described. The cancer types also explained. The WHO data of various new cases of cancer are depicted in the form of graph.
openaire +1 more source
Cancer Letters, 2007
Several groups have reported in recent years that members of the plant stress hormones family of jasmonates, and some of their synthetic derivatives, exhibit anti-cancer activity in vitro and in vivo. Jasmonates increased the life span of EL-4 lymphoma-bearing mice, and exhibited selective cytotoxicity towards cancer cells while sparing normal blood ...
openaire +2 more sources
Several groups have reported in recent years that members of the plant stress hormones family of jasmonates, and some of their synthetic derivatives, exhibit anti-cancer activity in vitro and in vivo. Jasmonates increased the life span of EL-4 lymphoma-bearing mice, and exhibited selective cytotoxicity towards cancer cells while sparing normal blood ...
openaire +2 more sources